1. HBW Insight
  2. >>Health
  3. >>Business

US FDA Clearance For Masimo’s Stork Wakes Up OTC Baby Monitoring Technology Competition

 
• By Malcolm Spicer

Masimo receives US regulatory clearance for Stork OTC baby monitoring system six months after Owlet received first clearance for its Dream Sock following a regulatory stumble which halted sales of a previous device, Smart Sock, in 2021.

• Source: Shutterstock

Masimo Corp. has received US regulatory clearance for its Stork OTC baby monitoring system six months after a competitor pioneered the market following its regulatory stumble which halted sales of a previous device in 2021.

Masimo on 6 May said OTC Stork is made with the same pulse oximetry technology that is used in its...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

Reckitt Strikes Deal To Sell Essential Home Unit To Focus On CHC, Hygiene

 
• By Tom Gallen

Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.

People On The Move: Appointments At Opella, Stada, Futura

 
• By Tom Gallen

Latest European appointments: Opella names Germany director; Stada has new Western Europe head; Futura makes CEO change.

Kenvue Makes CEO Change Months After Critical Activist Investor Made Proxy Play For Board Seat

Thibaut Mongon is out as Kenvue CEO, a post he’s held since J&J spun it out in July 2023, after the firm’s results came under increased investor scrutiny over the past year. The board appointed as interim CEO Kirk Perry, a board member since December who most recently headed technology, data and pre

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

 
• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

More from Health